Close Menu

Earlier this year, Leigh Anderson made a compelling argument in a Genome Technology cover story on biomarkers that without the validation step, biomarker discovery on its own doesn't mean a whole lot. "You could say that a biomarker candidate is discovered with proteomics," Anderson told us at the time, "but it’s possible to say that it’s really not a biomarker until you validate it. So, in a peculiar sense, the discovery actually occurs at the stage of validation."

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.